Marcos Bosi Ferraz

Marcos Bosi Ferraz

Auto-generated profile, based on publicly available information

Marcos Bosi Ferraz

Division of Rheumatology, Escola Paulista de Medicina, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1995
Verified
Journal Article
Closed access
JMJosé Eduardo Martinez
José Eduardo Martinez
MFM B Ferraz
M B Ferraz
ESEmilia Inoue Sato
Emilia Inoue Sato
EAE Atra
E Atra

8 November 2014 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
NBNatalie Botelho Borges
Natalie Botelho Borges
MFMarcos Bosi Ferraz
Marcos Bosi Ferraz
ACAntonio Roberto Chacra
Antonio Roberto Chacra
The worldwide increase of diabetes, a long duration, slow progression disease, impacts health care costs. The aim of this study was to estimate, from the society’s perspective, the annual cost per patient with Type 2 Diabetes (T2DM) at a specialized, outpatient center in the city of São Paulo, capital of São Paulo state, Brazil. Data from 209 patients were collected during the years 2009 and 2010 in a São Paulo diabetes care center which is part of the tertiary sector of SUS, Brazil’s National Health Care System. Data were collected by means of interviews and reviews of medical charts, and the quality of life was appraised using the SF36-v2 questionnaire. Direct medical costs were divided in five categories: 1) medication; 2) laboratory tests; 3) hospitalizations and procedures; 4) reactive strips for capillary blood glucose monitoring; and 5) medical consultations. Direct non-medical costs referred to transportation of patient and companion for treatment. Indirect costs included early retirements, sick leave and absenteeism in the workplace. Statistical analysis of the data was performed by the SPSS software, version 17.0. Our sample comprised 122 women (58%) and 87 men (42%), with mean age of 63 years and average diabetes duration of 13 years. The mean annual cost was US$ 1,844 per patient, out of which US$ 1,012 corresponded to direct costs (55%) and US$ 831 to indirect costs (45%). From the direct medical costs, medications accounted for the greatest proportion (42%), followed by reactive strips (27%), hospitalizations and procedures (14%), laboratory tests and image examinations (7%), as well as medical consultations (4%). Non-medical costs (transportation) corresponded to 7% of the total direct costs. Besides, the results indicated that men have better quality of life than women. This study demonstrated a high T2DM cost in Brazil, considering the governmental per capita expenses in health care, which accounted for US$ 466 in 2010 (World Health Statistics 2013 96-104 2013). Taking into account the high prevalence of the disease (IDF Diabetes Atlas. 5th edition. 29-48 2012), this survey recommends the enforcement of policies for the prevention of diabetes and its complications, and urges for better allocation of healthcare resources.

1 January 2010 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
ACAlessandro G. Campolina
Alessandro G. Campolina
ABAdriana Bruscato Bortoluzzo
Adriana Bruscato Bortoluzzo
MFMarcos Bosi Ferraz
Marcos Bosi Ferraz
RCRozana Mesquita Ciconelli
Rozana Mesquita Ciconelli
Compare the preference measures derived from the SF-36, based on the two Brazilian versions of the Short Form 6 Dimensions questionnaire-Brazil (SF-6D Brazil). Observational and transversal study. The following quality of life assessment instruments were applied: HAQ, SF-36, EQ-5D and SF-6D (1998 and 2002 versions). Descriptive statistics and correlation coefficients were used for data analysis. The study assessed 200 patients suffering from rheumatoid arthritis, with a mean age of 49.22 years, mean time with the disease of 11.16 years and mean HAQ score of 1.02. Preferences measured by the two versions of the SF-6D and by the EQ-5D showed significant correlations with one another, and Pearson coefficients ranged from 0.59 to 0.88 (p<0.01). The most current version of the SF-6D, based on the 2002 model, was found to be valid when compared to the version initially validated to Brazil and is a questionnaire alternative to assess preferences in economic analyses carried out in health care.

18 April 2015 in Quality of Life Research
Verified
Journal Article
Closed access
PDF file
RCRozana Mesquita Ciconelli
Rozana Mesquita Ciconelli
MFMarcos Bosi Ferraz
Marcos Bosi Ferraz
SKSérgio Kowalski
Sérgio Kowalski
GPGeraldo da Rocha Castelar Pinheiro
Geraldo da Rocha Castelar Pinheiro
ESEmilia Inoue Sato
Emilia Inoue Sato

1 November 1992 in The Journal of Hand Surgery
Verified
Journal Article
Closed access
PDF file
MFMarcos Bosi Ferraz
Marcos Bosi Ferraz
RCRozana Mesquita Ciconelli
Rozana Mesquita Ciconelli
PAPola Maria P. Araujo
Pola Maria P. Araujo
LOLeda Magalhaes Oliveira
Leda Magalhaes Oliveira
EAEdgard Atra
Edgard Atra

1 May 2015 in Cost Effectiveness and Resource Allocation
Verified
Journal Article
Open access
PDF file
MFMarcos Bosi Ferraz
Marcos Bosi Ferraz
The exponential increase of knowledge in the life sciences field, more specifically in health sciences, in the past few years has brought additional levels of complexity when deciding and implementing strategies in the health care system. A predominantly paternalistic way to decide about available options to maintain or improve individual or collective health has been moving to a shared-decision model considering the empowered patient. In spite of the reduction of uncertainty when making health and health care decisions due to the advancement in scientific methods, and, in spite of the asymmetry of information, knowledge and power to make decisions, we are progressively recognizing the importance of individuals, the target of the intervention, to express their preferences and to take an active role in the decision making process. Health care stakeholders, recognizing the scarcity of resources available and the fortunate ever increasing amount of applicable knowledge and its corresponding interventions to improve the population quantity and quality of life, should stimulate society to address and discuss health care issues that will guide critical choices and define health care priorities based mostly on judgment and the best evidence available.